Literature DB >> 1697365

Kallikrein multigene families and the regulation of their expression.

S R Murray1, J Chao, F K Lin, L Chao.   

Abstract

Tissue kallikreins are a group of closely related serine proteinases that are represented by multigene families in mice and rats. The existence of similar, large, kallikrein-like gene families in other mammalian species is currently a matter of dispute. We have surveyed a number of vertebrate species using genomic DNA Southern blotting and screened a human genomic library with a monkey kallikrein cDNA probe. The hybridization patterns of the genomic Southern blots and the characterization of 19 independent human clones using restriction analysis and Southern blotting indicate that other mammalian species may have multiple kallikrein-like genes as well. The regulatory mechanisms that govern the expression, activity, and bioavailability of tissue kallikreins are likewise complex. At the level of transcription, hormones, dietary factors, and tissue-specific factors are known to affect the expression of tissue kallikrein genes. At the posttranslational level, kallikrein activity and bioavailability are regulated by enzymatic activation, circulating autoantibodies, and binding proteins. We have demonstrated the presence of kallikrein-binding proteins in humans and rats, and, furthermore, we have shown reduced levels of this binding protein in a hypertensive rat model.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697365

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

1.  Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice.

Authors:  W Xiong; J Wang; L Chao; J Chao
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  The influence of age, sex and race on salivary kallikrein levels in human mixed saliva.

Authors:  J W Jenzano; S L Hogan; R L Lundblad
Journal:  Agents Actions       Date:  1992-01

Review 3.  Wnt pathway antagonists and angiogenesis.

Authors:  Bin Zhang; Jian-Xing Ma
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

Review 4.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Differences in the glycosylation of rat submandibular kallikreins.

Authors:  X S Zhang; G B Proctor; J R Garrett; D K Shori; G H Carpenter
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

6.  Inclusion of conserved buried water molecules in the model structure of rat submaxillary kallikrein.

Authors:  E F Henriques; M J Ramos; C A Reynolds
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

7.  Expression and characterization of rat kallikrein-binding protein in Escherichia coli.

Authors:  J X Ma; L Chao; G Zhou; J Chao
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

Review 8.  Development biology of the renal kallikrein-kinin system.

Authors:  S S el-Dahr
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

9.  Elevated tissue kallikrein activity in airway secretions from patients with tracheobronchitis associated with prolonged mechanical ventilation.

Authors:  T G O'Riordan; M D Weinstein; W M Abraham; R Forteza
Journal:  Lung       Date:  2003       Impact factor: 2.584

10.  SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload.

Authors:  Bin Zhang; Jian-xing Ma
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.